Trehalose is a potent PCR enhancer: lowering of DNA melting temperature and thermal stabilization of taq polymerase by the disaccharide trehalose.

References 1. Ostermeier C, Iwata S, Michel H. Cytochrome c oxidase. Curr Opin Struct Biol 1996;6:460–6. 2. Sullivan JL, Ochs HD. Copper deficiency and the immune system. Lancet 1978;2:686. 3. Vyas D, Chandra RK. Thymic factor activity, lymphocyte stimulation response and antibody producing cells in copper deficiency. Nutr Res 1983;3:343–50. 4. Araya M, Koletzko B, Uauy R. Copper deficiency and excess in infancy: developing a research agenda. J Pediatr Gastroenterol Nutr 2003;37: 422–9. 5. Widdowson E. Trace elements in fetal and early postnatal development. Proc Nutr Soc 1974;33:275–84. 6. Al-Rashid RA, Sprangler J. Neonatal copper deficiency. N Engl J Med 1971;285:841–3. 7. Ashkenazi AS, Levin S, Djaldetti M, Fisher E, Benvestini D. The syndrome of neonatal copper deficiency. Pediatrics 1973;52:523–33. 8. William DM. Copper deficiency in humans. Semin Hematol 1983;20:118– 28. 9. Cizewski-Culuta V, Gitlin JD. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, eds. Metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill, 2000:3105–28. 10. Hannam S, McDonnell M, Rennie IM. Investigation of prolonged neonatal jaundice. Acta Pediatr 2000;89:694–7. 11. Maisel JM. Jaundice in neonatology. In: Avery GB, Fletcher MA, McDonald MG, eds. Pathophysiology and management of the newborn, 4th ed. Philadelphia: JB Lippincott, 1994:630–60. 12. Henry RJ, Chiamoris N, Jacobs SL, Seaglove M. Determination of ceruloplasmin oxidase activity in serum. Proc Soc Exp Med Biol 1960;104:620–4. 13. Terres-Martos C, Navarro-Alarcon M, Martin-Lagos F, Lopez-Carcia de la Serrana H, Lopez Martinez MC. Determination of Cu levels in serum of healthy subjects by atomic absorption spectrometry. Sci Total Environ 1997;198:97–103. 14. Bremer J. Manifestations of copper excess. Am J Clin Nutr 1998;67(Suppl): 1069–73. 15. Fuentealba C, Aburto EM. Animal models of copper-associated liver disease. Comp Hepatol 2003;2:1–12. 16. Valaes T, Karaklis A, Stavrakakis D, Bavela-Stavrakakis K, Perakis A, Doxiadis SP. Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency. Pediatr Res 1969;3:448– 58. 17. Kaplan M, Beutler E, Vreman HJ, Hammerman C, Levy-Lahad E, Renbau P, et al. Neonatal hyperbilirubinemia in G6PD deficient heterozygotes. Pediatrics 1999;104:68–74. 18. Rossipal E, Krachler M, Li F, Micetic-Turk D. Investigation of the transport of trace elements across barriers in humans: studies of placental and mammary transfer. Acta Paediatr 2000;89:1190–5. 19. Chen BH, Tsai JL, Tsai LY, Chao MC. Comparison of serum copper, magnesium, zinc and calcium levels between G6PD deficient and normal Chinese adults. Kaohsiung J Med Sci 1999;15:646–50. 20. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson disease. Indications and outcome. Hepatology 1994;19:583–7. 21. Strand S, Hofmann WS, Grambihler A, Hug H, Volkmann M, Otto G, et al. Hepatic failure and liver cell damage in acute Wilson’s disease involve CD 95 (Apo-I/Fas) mediated apoptosis. Nat Med 1998;4:588–93. 22. Suzuki KT, Shiobara Y, Tachibana A, Ogra Y, Matsumoto K. Copper increases in both plasma and red cells at the onset of acute hepatitis. Res Commun Mol Pathol Pharmacol 1999;103:189–94. 23. Sokol RJ. Antioxidant defenses in metal induced liver damage. Semin Liver Dis 1996;16:39–46. 24. Fridovich J. Superoxide anion radical superoxide dismutases and related matters. J Biol Chem 1997;272:515–7. 25. Sokol RJ, McKim JM, Devereau MW. -Tocopherol ameliorates oxidant injury of isolated copper overloaded rat hepatocytes. Am J Clin Nutr 1998; 67(Suppl):1012–6. 26. Fridovich J. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995;64:97–112. 27. Van Wassenaer-van Hall HN. Neuroimaging in Wilson’s disease. Metab Brain Dis 1996;12:1–19.